Day One Biopharmaceuticals
DAWN
DAWN
66 hedge funds and large institutions have $430M invested in Day One Biopharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
38% less capital invested
Capital invested by funds: $698M → $430M (-$269M)
Holders
66
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$10.9M | |
| 2 | +$5.77M | |
| 3 | +$4.08M | |
| 4 |
Millennium Management
New York
|
+$1.73M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.12M |
Top Sellers
| 1 | -$6.44M | |
| 2 | -$4.08M | |
| 3 | -$2.34M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$1.2M |
| 5 |
DM
Deerfield Management
New York
|
-$1.15M |